FDA DEVICE FACTS
Ambu® NeurolineTM Cup MRI/CT (Models 72704/21US, 72704/23US, 72704/25US, 72704/27US) Ambu® NeurolineTM Cup MRI/CT-set (Models 72704/21-1010US, 72704/21-1010US, 72704/23-1010US, 72704/25-1010US, 72704/27-1010US) Ambu® NeurolineTM Cup MRI/CT-mini set (Models 72704/21-0301US, 72704/23-0301US, 72704/25-0301US, 72704/27-0301US)
Ambu A/S
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The Ambu® Neuroline™ Cup MRI/CT is intended to obtain and transmit electroencephalography (EEG) or evoked potential (EP) signals to the compatible Ambu harness, from where the signals can be transmitted to a monitoring and recording device.
The Ambu® Neuroline™ Cup MRI/CT is intended to be disconnected from all harness cables and left in place on the patient during Magnetic Resonance (MR) imaging and Computerized Tomography (CT) scanning.
The Ambu® Neuroline™ Cup MRI/CT is indicated when there is a need for neurophysiological examination of the brain.
The Ambu® Neuroline™ Cup MRI/CT can be used for adults and pediatrics (from 2 years and older).
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。